Tissue Models For Therapeutics - Aug 29th-30th 2005

1 post / 0 new
Fraser Moss
Fraser Moss's picture
Tissue Models For Therapeutics - Aug 29th-30th 2005

Cells, tissues, and organs function in a 3-D environment. Ideally, cell-based models that capture both the 3-D organization and multicellular complexity of the target system provide the most powerful tools for screening the effects of therapeutic candidates. This meeting bridges tissue engineers who are constructing the 3-D models with biologists who are studying healthy vs. diseased states and pharmacologists who are developing high-throughput screening assays. As with 3-D biological models, each specialty provides insight into the complete system. CHI's 2nd Annual Tissue Models for Therapeutics is a pharmaceutical conference where the attendees you meet are as important as the faculty.

REGISTRATION - http://www.healthtech.com/2005/TBS/

Keynote Presentation
Cells and Tissues in Context: Culture Models for the 21st Century!
Dr. Mina J. Bissell, Distinguished Scientist, Lawrence Berkeley National Laboratory

2-D vs. 3-D Models
A Biophysical Perspective of Epithelial Morphogenesis, Malignancy and Treatment Responsiveness
Ms. Nastaran Zahir, Member, Institute for Medicine and Engineering, University of Pennsylvania

Mining Databases to Find the Genes that Determine the Intractability of Human Tumors
Dr. Wilfred Stein, Professor, Cancer Therapeutics Branch, National Cancer Institute, NIH

Correlations of in vitro and in Vivo Assays
Using Human Primary Cells to Assess Population Response to Drug Candidates Before Clinical Trials: A Case Study with Diabetes Therapeutics
Dr. Simon Goldbard, Founder and VP of R&D, VitraBioscience

Large Scale Compound Profiling using Complex Human Primary Cell-Based Assay Systems
Dr. Ivan Plavec, Senior Director, Technology Development, BioSeek, Inc.

Stem Cell Models for Screening Assays
Stem Cell Models for Target Validation, Drug Screening and Safety Assessment
Dr. John Hambor, Associate Research Fellow, Experimental Medicinal Chemistry, Pfizer Global Research and Development

Using Motor Neurons Derived From Embryonic Stem Cells for Drug Discovery
Dr. Amy Sinor, Researcher, Assay Development, Curis

A Novel Functional Assay of Cell Binding by a Medical Device/Implant
Dr. Mary Zacour, Principal Scientist, In Vitro Assay Development, Metabolism Resource, MDS Pharma Services

Engineering Higher Throughput Screening Environments
Using Automated Microcarrier-Based Cell Culture to Improve Human Cell Phenotype
Dr. Robin Felder, Professor of Pathology and Medical Automation, University of Virginia
Panel of Experts: Engineering a Functional High-Throughput Tissue Screening System

3-D Tissue ThinkTanks
Time has been designated for facilitated interactive discussions in groups with specific themes. This unique opportunity allows conference participants to focus on a topic in depth to exchange ideas, information, experiences, and develop future collaborations.
Topics for Discussion Include:
Engineering More in Vivo Physiological Environments
Creating Higher Throughput
Cell Source Considerations
2-D vs. 3-D Advantages for Drug Discovery
Cultured Cells vs. Tissue

Applications in Drug Discovery
Tissue Model Mechanics for Drug Discovery
Dr. Tetsuro Wakatsuki, Chief Scientist, Research & Development, InvivoSciences LLC

Three Dimensional Tumor Models for Drug Discovery in Prostate Cancer
Dr. Norman Maitland, Chief Scientific Officer, Pro-Cure Therapeutics

Three-Dimensional Human Tissue Models for Drug Discovery and Therapeutic Applications for Infectious Disease
Dr. Cheryl Nickerson, Associate Professor, Microbiology and Immunology, Tulane University Health Sciences Center

Scientific Advisors
Dr. Angela Cacace, Bristol-Myers Squibb Co.
Dr. Jonathan Garlick, Tufts University
Dr. Linda Griffith, Massachusetts Institute of Technology
Dr. Robert Langer, Massachusetts Institute of Technology

This Conference is running concurrently with
Stem Cell Research, August 29-31, 2005

Register by June 3rd, 2005 and Save up to $350

For more information, please contact, fax or e-mail submissions to:
Mary Ann Brown, Senior Conference Director, Cambridge Healthtech Institute
Fax: 617 630-1325 E-mail: eval(unescape('%64%6f%63%75%6d%65%6e%74%2e%77%72%69%74%65%28%27%3c%61%20%68%72%65%66%3d%22%6d%61%69%6c%74%6f%3a%6d%61%62%72%6f%77%6e%40%68%65%61%6c%74%68%74%65%63%68%2e%63%6f%6d%22%3e%6d%61%62%72%6f%77%6e%40%68%65%61%6c%74%68%74%65%63%68%2e%63%6f%6d%3c%2f%61%3e%27%29%3b'))

For exhibits and sponsorship information, please contact:
Carol Dinerstein, Manager of Business Development
Phone: 617-630-1371 E-mail: eval(unescape('%64%6f%63%75%6d%65%6e%74%2e%77%72%69%74%65%28%27%3c%61%20%68%72%65%66%3d%22%6d%61%69%6c%74%6f%3a%64%69%6e%65%72%73%74%65%69%6e%40%68%65%61%6c%74%68%74%65%63%68%2e%63%6f%6d%22%3e%64%69%6e%65%72%73%74%65%69%6e%40%68%65%61%6c%74%68%74%65%63%68%2e%63%6f%6d%3c%2f%61%3e%27%29%3b'))